Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Centogene NV | CNTG | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.4701 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4701 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.431 - 2.52 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.4701 | USD |
Centogene NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 12.97M | 27.60M | - | 66.93M | -31.84M | -1.15 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Centogene NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNTG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.50 | 0.5498 | 0.431 | 0.469579 | 127,633 | -0.0299 | -5.98% |
| 1 Month | 0.686 | 0.75 | 0.431 | 0.6142654 | 125,977 | -0.2159 | -31.47% |
| 3 Months | 1.13 | 1.2358 | 0.431 | 0.6702465 | 61,907 | -0.6599 | -58.40% |
| 6 Months | 1.06 | 1.53 | 0.431 | 0.8901546 | 43,517 | -0.5899 | -55.65% |
| 1 Year | 0.73 | 2.52 | 0.431 | 1.43 | 537,530 | -0.2599 | -35.60% |
| 3 Years | 11.18 | 11.95 | 0.431 | 1.92 | 198,047 | -10.71 | -95.80% |
| 5 Years | 14.10 | 36.00 | 0.431 | 3.78 | 160,156 | -13.63 | -96.67% |
Centogene NV Description
| Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. |
